PIIIW Enterprise Value Over E B I T D A from 2010 to 2025
| PIIIW Stock | USD 0.02 0 20.00% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (2.33) | Current Value (2.45) | Quarterly Volatility 4.85016757 |
Check P3 Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among P3 Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 104.7 M, Interest Expense of 17.5 M or Selling General Administrative of 133.7 M, as well as many indicators such as Price To Sales Ratio of 0.11, Dividend Yield of 0.0 or PTB Ratio of 0.96. PIIIW financial statements analysis is a perfect complement when working with P3 Health Valuation or Volatility modules.
PIIIW | Enterprise Value Over E B I T D A |
Latest P3 Health's Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of P3 Health Partners over the last few years. It is P3 Health's Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in P3 Health's overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
PIIIW Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (8.62) | |
| Geometric Mean | 5.70 | |
| Coefficient Of Variation | (56.26) | |
| Mean Deviation | 4.29 | |
| Median | (11.50) | |
| Standard Deviation | 4.85 | |
| Sample Variance | 23.52 | |
| Range | 13.9718 | |
| R-Value | 0.74 | |
| Mean Square Error | 11.32 | |
| R-Squared | 0.55 | |
| Significance | 0.001 | |
| Slope | 0.76 | |
| Total Sum of Squares | 352.86 |
PIIIW Enterprise Value Over E B I T D A History
About P3 Health Financial Statements
P3 Health investors use historical fundamental indicators, such as P3 Health's Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in P3 Health. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (2.33) | (2.45) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for PIIIW Stock Analysis
When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.